🔗 Permalink

Inventor profile of:

Ari E. Friedland

City:

Boston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-09-05

Top Assignees for applications by Ari E. Friedland

The entities that hold a legal rights for patent applications filed by inventor Friedland Ari E.:

EDITAS MEDICINE, INC. 16 Cambridge, MA United States
DUKE UNIVERSITY 1 Durham, NC United States

Recent patent applications by Friedland Ari E.

Ari E. Friedland from Boston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-05

US20240294917A1

Chemistry; metallurgy

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)

#2 | 2023-12-28

US20230416787A1

Chemistry; metallurgy

Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA

#3 | 2023-01-26

US20230026726A1

Chemistry; metallurgy

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE

#4 | 2022-01-20

US20220017927A1

Chemistry; metallurgy

Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA

#5 | 2022-01-13

US20220010313A1

Chemistry; metallurgy

CRISPR/CAS-related methods and compositions for treating herpes simplex virus

#6 | 2021-12-09

US20210380987A1

Chemistry; metallurgy

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

#7 | 2020-02-20

US20200056208A1

Chemistry; metallurgy

Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA

#8 | 2019-08-15

US20190249157A1

Chemistry; metallurgy

CRISPR/cas-related methods and compositions for treating herpes simplex virus

#9 | 2018-09-06

US20180251792A1

Chemistry; metallurgy

Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA

#10 | 2018-09-06

US20180251770A1

Chemistry; metallurgy

CRISPR/Cas-related methods and compositions for treating herpes simplex virus

#11 | 2018-08-23

US20180236103A1

Human necessities

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HEPATITIS B VIRUS

#12 | 2018-07-19

US20180201956A1

Chemistry; metallurgy

Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA

#13 | 2018-05-08

US15832567

Chemistry; metallurgy

Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA

#14 | 2017-11-02

US20170314015A1

Chemistry; metallurgy

CRISPR/CAS-related methods and compositions for treating sickle cell disease

#15 | 2017-06-22

US20170175128A1

Chemistry; metallurgy

CRISPR-CAS-RELATED METHODS, COMPOSITIONS AND COMPONENTS FOR CANCER IMMUNOTHERAPY

#16 | 2017-03-16

US20170073685A1

Chemistry; metallurgy

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HERPES SIMPLEX VIRUS TYPE 1 (HSV-1)

#17 | 2017-01-26

US20170022507A1

Chemistry; metallurgy

CRISPR/CAS-related methods and compositions for treating cystic fibrosis

#18 | 2017-01-12

US20170007679A1

Human necessities

CRISPR/CAS-RELATED METHODS AND COMPOSITIONS FOR TREATING HIV INFECTION AND AIDS

InventorID:

1765992 ⎘